At a given external dose of an inhaled chemical the internal dose or the amount absorbed into the body varies depending on pulmonary ventilation and other physiological factors. Such variability is of concern in the development of biological indices of occupational exposure to organic solvent vapours. This paper discusses how physiological factors may influence the pharmacokinetic behaviour of inhaled organic solvent vapours, especially in relation to monitoring of biological exposure. To illustrate the discussion a computer based physiological pharmacokinetic model was used describing quantitatively the influence of body size, body fat content, and sex on the pharmacokinetic behaviour of trichloroethylene. Absorption, distribution, metabolism and excretion of trichloroethylene were found to vary according to the different anatomical features of men and women. Body build (body weight and body fat content) also affected the pharmacokinetic behaviour of this solvent. Biological monitoring of exposure is a measure of the amount of chemical absorbed into the body and is performed by measuring the concentration of chemical or its metabolites in biological samples. Any physiological factor which influences the absorption, distribution, metabolism, or elimination of a chemical can affect the result of exposure monitoring. A physiological pharmacokinetic model is a useful tool to obtain an insight into these effects, as each compartment employed in the model represents a particular tissue or organ group of anatomical significance. The impact of body size and physical activity on the pharmacokinetic behaviour of organic solvents has been studied with this type of model.' 2 The aim of our paper is to discuss and show how two factors-namely, body build (body weight and body fat content) and sex-may affect biological monitoring of exposure to organic solvents. A physiological simulation model for trichloroethylene provides an example.
age, body build, and most prominently with energy expenditure.
Biological monitoring of exposure is a measure of the amount of chemical absorbed into the body and is performed by measuring the concentration of chemical or its metabolites in biological samples. Any physiological factor which influences the absorption, distribution, metabolism, or elimination of a chemical can affect the result of exposure monitoring. A physiological pharmacokinetic model is a useful tool to obtain an insight into these effects, as each compartment employed in the model represents a particular tissue or organ group of anatomical significance. The impact of body size and physical activity on the pharmacokinetic behaviour of organic solvents has been studied with this type of model.' 2 The aim of our paper is to discuss and show how two factors-namely, body build (body weight and body fat content) and sex-may affect biological monitoring of exposure to organic solvents. A physiological simulation model for trichloroethylene provides an example.
Methods
Our simulation model was composed of seven compartments: the lung compartment, vessel rich tissue compartment, vessel poor tissue compartment, muscle compartment, fat tissue compartment, gastrointestinal compartment, and hepatic compartment.3 To describe the transfer of trichloroethylene in the system, an equilibrium was assumed always to exist between the concentration in a compartment and the concentration in the blood leaving the compartment. The loss of trichloroethylene by metabolism was assumed to occur only in the hepatic compartment and follow Michaelis-Menten type kinetics. Thus the rate of metabolism was expressed by the formula Vmax-CH/(Km + CH), where Vmax is the maximum velocity, Km the Michaelis constant, and CH the concentration of trichloroethylene in the hepatic compartment. It was also assumed that trichloroethylene is first metabolised to chloral hydrate, which is then converted to trichloroacetic acid (TCA) and trichloroethanol (TCE). A fraction of TCA is formed from TCE. The TCA and TCE are excreted in the urine either directly or after conjugation;
For the transfer of trichloroethylene metabolites, the whole body was treated as a single compartment and first order kinetics were assumed for the sake of simplicity.4 A mass balance of trichloroethylene was performed on each compartment and its transfer throughout the system was expressed in the form of simultaneous differential equations that were then solved numerically with a personal computer.35 The Because alveolar ventilation depends on body weight, absorption into the body increased with increased body weight. Increased uptake was not reflected, however, by a similar increase in the blood concentration of the solvent because it was diluted in a larger volume ( fig 1A) . On the other hand, the amounts of metabolites TCA and TCE excreted in urine increased with body size ( fig 1B) . This is not surprising because liver size increases proportionately with body weight and metabolic capacity (Vmax) increases with a power function of body weight. The urinary concentration of metabolites Three types ofman were chosen-namely, a standard 4.00 man (body weight 70 kg) with 14-8 1 (corresponding to 0 21lBw) ofbody fat, an obese man with 29 6 1, and a slim man with 7-4 1. Blood flow through the fat tissue was changed proportionately according to the tissue volume. All physiological parameters other than the volume and blood flow of fat tissue were assumed to be the same. These men were exposed to 50 ppm trichloroethylene for eight hours (8:00-12:00 and 13:00-17:00 hours), and the concentration of trichloroethylene in the blood and the rate of metabolite excretion into the urine were computed over time during and after the exposure. Trichloroethylene concentration in the blood during exposure was highest in the slim and lowest in the 40kg obese man (fig 2A) . Similarly, the amount of urinary metabolites excreted by the obese man was smaller than that excreted by the standard or slim man ( fig  2B) . As the fat-blood partition coefficient of trichloroethylene is very large (68), trichloroethylene is almost completely extracted from blood passing through fat tissues. Thus during exposure, fat tissue acts as an efficient scavenger of trichloroethylene. Accordingly, the amount of trichloroethylene available for metabolic transformation decreases with increasing obesity.
In due course after exposure the rate of trichloroethylene removal from fat tissue begins to rate limit the overall transfer of trichloroethylene. At this time the amount of trichloroethylene released from the fat tissue of the obese man is almost twice as large and that from the slim man half as large as that of the standard man. Consequently, three hours after exposure (20:00 hours) the blood concentration of trichloroethylene was reversed among the three subjects, and 16 hours after exposure the concentration in the obese man was about twice as high and in the slim man half as high as that of the standard man (fig 2A) . The amounts of urinary metabolites were also reversed among the three subjects in the final stage.
The conclusion described above was drawn from a simulation study in which the blood flow through fat tissue was assumed to change in proportion to the volume of the tissue. As the rate of trichloroethylene transfer to and from fat tissue is determined by the volume offat tissue and the blood flow through it, the result of such a simulation study is expected to be dependent on the relation between the volume of fat tissue and the blood flow used. This was confirmed by a simulation study where the volume of fat tissue was kept at a level of 29-6 1 (the same as that of the obese man described above) with three different blood flows through the tissue-namely, 0-31 1/min (1/2 that of the obese man), 0-46 1/min (3/4 that of the obese man), or 0-62 1/min (the same as that of the obese man) (fig 3) . During exposure, the higher the blood flow, the lower the trichloroethylene concentration in blood, although the concentration was highest in the obese man with the highest blood flow about three hours after the end of exposure ( fig 3A) . In accordance with this, the higher the blood flow through fat tissue, the lower the rate of urinary metabolite excretion ( fig 3B) . The reason was mentioned earlier.
In the long run, however, the rate in the obese man with the higher blood flow surpassed that in the man with the lower blood flow (data not shown). volume ofbfat tissue 0365 Bw as opposed to 0415 Bw and 0-211 Bw for male workers. The reason for choosing this value as the volume of the fat compartment in women was because according to Nagamine and Suzuki'4 content of body fat in Japanese men was 115% of body weight, whereas that of women was 19 9%. The fat content in a standard woman (F) was thus calculated to match with that of a standard man (0 211 Bw) according to Davis and Mapleson"°by using the equation F = 0 211 x (19 9/11.5). The blood perfusion through muscle or fat tissue was changed proportionally according to the change in volume of each tissue. The cardiac output of women was set at a level 10% less than that of men according to Guyton, 12 and thus calculated from the formula 0-266 (Bw)°'. The Vmax and Km were assumed to be sex independent, as there are no indications of sex related differences in drug metabolism in man.'3 The urinary output ofwomen was also assumed to be 10% less than that of men and is hence expressed by the formula 2-77 x 10-(Bw)'82.
A standard man (70 kg) and woman (60 kg) were submitted to a 50 ppm x In this simulation study, the specific activity of drug metabolising enzymes in the liver was assumed -Woman to be equal in both sexes. The female liver, however, Man-- is smaller in size than that of the man. Hence, the rate 400 8.00
of overall trichloroethylene metabolism was accordingly lower in the woman. Together with the lesser amount absorbed, lesser amounts ofmetabolites were excreted in urine by the woman (fig 4B) . The urinary metabolite concentration was also lower in the woman than in the man ( fig 4C) although the difference was not so great as that seen in the rate of excretion. Agreeing with this simulation study, previous experimental studies'5 16 have shown that women retain trichloroethylene in the body in a lesser amount and excrete a lesser amount of metabolites in the urine than do men. Knowledge of the toxicokinetics of chemicals is a basic requirement for understanding the relation between external and internal doses. Physiological factors such as sex and body build can alter this relation. Computer based physiological simulation models provide us with useful information particularly in this regard. The simulations presented in this report, however, are not intended as exac: predictions of the kinetic behaviour of trichloroethylene in industrial workers. Such predictions are of limited value as many of the conditions under which the simulations are made are only theoretical and do not reflect real exposure condi-. | tions. Our report should rather be regarded as an 4.00 800
example of how such a model may be of value in elucidating some kinetic aspects of human exposure ehaviour of to organic solvent vapours. 
